Psychiatric Drugs For Children Approved By Expert Panel
Posted on: Thursday, 11 June 2009, 06:15 CDT
Although psychiatric drugs in children and adolescents can increase the risk of diabetes, Food and Drug Administration advisers still claim the drugs seem safe and effective for treatment of certain conditions, the Associated Press reported.
Drugs by AstraZeneca, Eli Lilly and Pfizer are seemingly safe and beneficial for the treatment of schizophrenia and bipolar disorder in individuals ages 10 to 17, according to an overwhelmingly supportive vote by the FDA’s panel of experts.
Adult use of the drug has already been approved for those suffering schizophrenia and bipolar disorder.
Typically, the FDA will make judgments in favor of the group’s recommendation, although it is not mandatory.
If the FDA agrees to the group’s advice, the use of the drugs, which already make up the leading class of prescriptions in the US, would increase significantly. Sales in 2008 equaled $14.6 billion, according to health care analysis firm IMS Health.
---
On the Net:
Source: redOrbit Staff & Wire Reports
Related Articles
- GAO to Enquire into FDA's Drug Approval Policies
- Sagient Research Reports Significant Decline in FDA Drug Approval Rate
- Mayo Clinic Questions FDA Drug Warning
- Report Faults FDA Drug Safety Practices
- IOM: Wide Gaps in FDA Drug-Safety Process
- Senators plan bill to revamp FDA drug safety
- PROFNET WIRE: HEALTH & MEDICINE: FDA Drug Approval
- Think Your Drugs Are Manufactured in America? Think Again! FDA, Drug Companies Deceive Americans About Where Their Prescription Drugs Come From
- US advisers criticize FDA drug safety board
- Sepracor's Arformoterol NDA Filed By FDA; Drug Candidate for Chronic Obstructive Pulmonary Disease Moves Into Formal Review
 |
 |
User Comments (1)
| 1. |
Posted by Marie on 06/20/2009, 13:26 This is terrible that they. are pushing drugs on children.Children just need to learn to deal with their emotions and channel their energies in constructive ways |
RSS Feeds